Skip to main content
. 2020 Mar 21;13(4):100756. doi: 10.1016/j.tranon.2020.100756

Figure 3.

Figure 3

Inter-laboratory reproducibility of BluePrint FFPE – comparison of BluePrint indices between two Agendia sites Amsterdam (location 1) and Irvine (location 2) (N = 97). A. BluePrint Luminal-type indices, B. BluePrint HER2-type indices, C. BluePrint Basal-type indices, D. BluePrint indices comparison for the final assigned subtype (Luminal-, HER2- and or Basal-type). BluePrint subtype concordance was 100%. Each dot represents a single breast cancer sample for which total RNA underwent BluePrint microarray laboratory processing and analysis.